Standard

The dopamine metabolite 3-methoxytyramine is a neuromodulator. / Sotnikova, TD; Beaulieu, JM; Espinoza, S; Masri, B; Zhang, X; Salahpour, A; Barak, LS; Caron, MG; Gainetdinov, RR.

In: PLoS ONE, 2010.

Research output: Contribution to journalArticle

Harvard

Sotnikova, TD, Beaulieu, JM, Espinoza, S, Masri, B, Zhang, X, Salahpour, A, Barak, LS, Caron, MG & Gainetdinov, RR 2010, 'The dopamine metabolite 3-methoxytyramine is a neuromodulator.', PLoS ONE.

APA

Sotnikova, TD., Beaulieu, JM., Espinoza, S., Masri, B., Zhang, X., Salahpour, A., Barak, LS., Caron, MG., & Gainetdinov, RR. (2010). The dopamine metabolite 3-methoxytyramine is a neuromodulator. PLoS ONE.

Vancouver

Sotnikova TD, Beaulieu JM, Espinoza S, Masri B, Zhang X, Salahpour A et al. The dopamine metabolite 3-methoxytyramine is a neuromodulator. PLoS ONE. 2010.

Author

Sotnikova, TD ; Beaulieu, JM ; Espinoza, S ; Masri, B ; Zhang, X ; Salahpour, A ; Barak, LS ; Caron, MG ; Gainetdinov, RR. / The dopamine metabolite 3-methoxytyramine is a neuromodulator. In: PLoS ONE. 2010.

BibTeX

@article{b806b2ffabbe4875937f8f051f4045b1,
title = "The dopamine metabolite 3-methoxytyramine is a neuromodulator.",
abstract = "Dopamine (3-hydroxytyramine) is a well-known catecholamine neurotransmitter involved in multiple physiological functions including movement control. Here we report that the major extracellular metabolite of dopamine, 3-methoxytyramine (3-MT), can induce behavioral effects in a dopamine-independent manner and these effects are partially mediated by the trace amine associated receptor 1 (TAAR1). Unbiased in vivo screening of putative trace amine receptor ligands for potential effects on the movement control revealed that 3-MT infused in the brain is able to induce a complex set of abnormal involuntary movements in mice acutely depleted of dopamine. In normal mice, the central administration of 3-MT caused a temporary mild hyperactivity with a concomitant set of abnormal movements. Furthermore, 3-MT induced significant ERK and CREB phosphorylation in the mouse striatum, signaling events generally related to PKA-mediated cAMP accumulation. In mice lacking TAAR1, both behavioral and signaling effects of 3-MT were",
author = "TD Sotnikova and JM Beaulieu and S Espinoza and B Masri and X Zhang and A Salahpour and LS Barak and MG Caron and RR. Gainetdinov",
year = "2010",
language = "не определен",
journal = "PLoS ONE",
issn = "1932-6203",
publisher = "Public Library of Science",

}

RIS

TY - JOUR

T1 - The dopamine metabolite 3-methoxytyramine is a neuromodulator.

AU - Sotnikova, TD

AU - Beaulieu, JM

AU - Espinoza, S

AU - Masri, B

AU - Zhang, X

AU - Salahpour, A

AU - Barak, LS

AU - Caron, MG

AU - Gainetdinov, RR.

PY - 2010

Y1 - 2010

N2 - Dopamine (3-hydroxytyramine) is a well-known catecholamine neurotransmitter involved in multiple physiological functions including movement control. Here we report that the major extracellular metabolite of dopamine, 3-methoxytyramine (3-MT), can induce behavioral effects in a dopamine-independent manner and these effects are partially mediated by the trace amine associated receptor 1 (TAAR1). Unbiased in vivo screening of putative trace amine receptor ligands for potential effects on the movement control revealed that 3-MT infused in the brain is able to induce a complex set of abnormal involuntary movements in mice acutely depleted of dopamine. In normal mice, the central administration of 3-MT caused a temporary mild hyperactivity with a concomitant set of abnormal movements. Furthermore, 3-MT induced significant ERK and CREB phosphorylation in the mouse striatum, signaling events generally related to PKA-mediated cAMP accumulation. In mice lacking TAAR1, both behavioral and signaling effects of 3-MT were

AB - Dopamine (3-hydroxytyramine) is a well-known catecholamine neurotransmitter involved in multiple physiological functions including movement control. Here we report that the major extracellular metabolite of dopamine, 3-methoxytyramine (3-MT), can induce behavioral effects in a dopamine-independent manner and these effects are partially mediated by the trace amine associated receptor 1 (TAAR1). Unbiased in vivo screening of putative trace amine receptor ligands for potential effects on the movement control revealed that 3-MT infused in the brain is able to induce a complex set of abnormal involuntary movements in mice acutely depleted of dopamine. In normal mice, the central administration of 3-MT caused a temporary mild hyperactivity with a concomitant set of abnormal movements. Furthermore, 3-MT induced significant ERK and CREB phosphorylation in the mouse striatum, signaling events generally related to PKA-mediated cAMP accumulation. In mice lacking TAAR1, both behavioral and signaling effects of 3-MT were

M3 - статья

JO - PLoS ONE

JF - PLoS ONE

SN - 1932-6203

ER -

ID: 5573563